Hence, these models may be better suited for early-onset AD, whereas the involvement of APOE4 may be more relevant to late-onset AD; thus, these results may not capture the effects of APOE4 as a major AD risk factor on meningeal lymphatic vessels. The gene discussed is APOE; the disease is Alzheimer disease.